Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomised controlled trial

Thorax

Volumn 73, Issue 7, 2018, Pages 634-643

  Vivodtzev, Isabelle ^a,b   Tamisier, Renaud ^a   Croteau, Marilie ^c   Borel, Jean Christian ^a   Grangier, Angélique ^a   Wuyam, Bernard ^a   Lévy, Patrick ^a   Minville, Caroline ^c   Sériès, Frédéric ^c   Maltais, François ^c   Pépin, Jean Louis ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Pulmonary Rehabilitation; Respiratory Muscles; Sleep Apnoea

Indexed keywords

ADULT; AEROBIC CAPACITY; APNEA HYPOPNEA INDEX; ARTICLE; BICYCLE ERGOMETRY; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY MASS; BREATHING MUSCLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIASTOLIC BLOOD PRESSURE; EXERCISE TOLERANCE; FEMALE; FUNCTIONAL STATUS; HUMAN; INTERACTIVE VENTILATORY SUPPORT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MUSCLE STRENGTH; MUSCLE TRAINING; NECK CIRCUMFERENCE; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; PARALLEL DESIGN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULSE WAVE; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF EXAMINATION; SINGLE BLIND PROCEDURE; SIX MINUTE WALK TEST; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WAIST CIRCUMFERENCE;

EID: 85047756200     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-211152     Document Type: Article

References (33)

1. Pépin JL, Tamisier R, Lévy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012;67:1025-7
2. L évy P, Kohler M, McNicholas WT, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 2015;1:15015
3. Mendelson M, Tamisier R, Laplaud D, et al. Low physical activity is a determinant for elevated blood pressure in high cardiovascular risk obstructive sleep apnea. Respir Care 2014;59:1218-27
4. T asali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008;133:496-506
5. McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016;375:919-31
6. Jullian-Desayes I, Joyeux-Faure M, Tamisier R, et al. Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. Sleep Med Rev 2015;21:23-38
7. West SD, Kohler M, Nicoll DJ, et al. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med 2009;10:1056-8
8. Mendelson M, Vivodtzev I, Tamisier R, et al. CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: a randomized, controlled trial. Sleep 2014;37:1863-70
9. C hirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 2014;370:2265-75
10. Pépin JL, Timsit JF, Tamisier R, et al. Prevention and care of respiratory failure in obese patients. Lancet Respir Med 2016;4:407-18
11. Salvadori A, Fanari P, Fontana M, et al. Oxygen uptake and cardiac performance in obese and normal subjects during exercise. Respiration 1999;66:25-33
12. Dreher M, Kabitz HJ, Burgardt V, et al. Proportional assist ventilation improves exercise capacity in patients with obesity. Respiration 2010;80:106-11
13. Villiot-Danger J-C, Villiot-Danger E, Borel J-C, et al. Respiratory muscle endurance training in obese patients. Int J Obes 2011;35:692-9
14. AT S Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. AT S statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7
15. Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;2007:1105-87
16. Vivodtzev I, Minet C, Tamisier R, et al. Arterial stiffness by pulse wave velocity in COPD: reliability and reproducibility. Eur Respir J 2013;42:1140-2
17. Minet C, Vivodtzev I, Tamisier R, et al. Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD. Respir Physiol Neurobiol 2012;183:128-34
18. Vivodtzev I, Mendelson M, Croteau M, et al. Physiological correlates to spontaneous physical activity variability in obese patients with already treated sleep apnea syndrome. Sleep Breath 2017;21:61-8
19. A iello KD, Caughey WG, Nelluri B, et al. Effect of exercise training on sleep apnea: a systematic review and meta-Analysis. Respir Med 2016;116:85-92
20. Mandal S, Suh ES, Harding R, et al. Nutrition and exercise rehabilitation in obesity hypoventilation syndrome (NERO): a pilot randomised controlled trial. Thorax 2018;73:62-9
21. Borel JC, Borel AL, Piper AJ. NERO: a pilot study but important step towards comprehensive management of obesity hypoventilation syndrome. Thorax 2018;73:5-6
22. G osselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence?. Eur Respir J 2011;37:416-25
23. Pankow W, Hijjeh N, Schüttler F, et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J 1997;10:2847-52
24. Maltais F, Reissmann H, Gottfried SB. Pressure support reduces inspiratory effort and dyspnea during exercise in chronic airflow obstruction. Am J Respir Crit Care Med 1995;151:1027-33
25. Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med 2014;11:e1001599
26. Stradling JR, Craig SE, Kohler M, et al. Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA. Thorax 2015;70:181-2
27. Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004;109:2191-6
28. C ostes F, Roche F, Pichot V, et al. Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD. Eur Respir J 2004;23:396-401
29. Fietze I, Romberg D, Glos M, et al. Effects of positive-pressure ventilation on the spontaneous baroreflex in healthy subjects. J Appl Physiol 2004;96:1155-60
30. Drager LF, Yao Q, Hernandez KL, et al. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med 2013;188:240-8
31. Hwang R, Bruning J, Morris N, et al. A systematic review of the effects of telerehabilitation in patients with cardiopulmonary diseases. J Cardiopulm Rehabil Prev 2015;35:380-9
32. Bailly S, Destors M, Grillet Y, et al. Obstructive sleep apnea: a cluster analysis at time of diagnosis. PLoS One 2016;11:e0157318
33. G agnadoux F, Le Vaillant M, Paris A, et al. Relationship between OSA clinical phenotypes and CPAP treatment outcomes. Chest 2016;149:288-90.